Asklepios BioPharmaceutical


Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.


Org chart

Collapse
R. Jude Samulski
President, Chief Scientific Officer & Co-Founder
Tracy Dowling
General Counsel & Head of Business Development
Melissa Murrell
Chief People Officer
Amanda Lowder
Executive Assistant To Chief Executive Officer
Jason Krentz
Chief Operating Officer
Ralph Herbst
Chief Strategy Officer
Candace Summerford
Chief Patent Officer
Canwen Jiang
Chief Development Officer & CMO

Board & advisors



Offices